Colorectal and kidney cancer represent the extremes of the spectrum with a favorable prognosis in colorectal cancers and a poor prognosis in RCCs with high amounts of CD8+ and CD8+Ki67+ cytotoxic T cells. This evidence concerns the gene MKI67 and kidney cancer.